APRIL 2026
Healthcare assets have ranked among the top priorities of financial investors for years. In the medical technology sector in particular, however, significant value creation potential remains largely untapped.
At the same time, the market is anything but straightforward. Regulatory requirements, technological depth and fragmented market structures make transactions in the MedTech sector particularly demanding — requiring a differentiated approach to both strategy and execution.
In the latest episode of “What’s up, Corporate Finance?”, industry experts Dr. Martin Reimer and Timo Peter discuss which deal strategies are currently proving particularly successful, how hidden potential can be unlocked and which types of Private Equity investors are especially well received by MedTech entrepreneurs.
The key takeaway: success in MedTech M&A is not determined by capital alone. What matters is a deep understanding of the sector, its dynamics and its operational specifics.
Against this backdrop, Göttingen Corporate Finance (GCF) and Medical Valley Solutions (MVS) work closely together to combine leading M&A expertise with in-depth MedTech know-how. This partnership brings together structured transaction management and deep sector knowledge — creating a unique platform for high-quality M&A processes.
Medical Valley is Germany’s leading and only officially designated excellence cluster for medical technology, as well as the largest MedTech cluster in the country. Combined with GCF’s end-to-end M&A expertise, this creates a differentiated setup for achieving optimal transaction outcomes.
Listen to the podcast, available wherever you get your podcasts:
